Kauh John Saewook M.D. reported TVRD

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002064881-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 29, 2026

Published

Feb 2, 2026

Ingested by INSIDER

Nov 5, 04:19 UTC

Last re-read

Nov 5, 04:19 UTC

Extracted facts

Filer

Kauh John Saewook M.D.

Role

Chief Medical Officer

Transaction

Grant or awardAs filed: “A”

Asset

Tvardi Therapeutics, Inc. — Employee Stock Option (right to buy)

Ticker

TVRD

Shares

45.0K

Price per share

$0

Execution date (reported)

Jan 29, 2026

Owned after transaction

45.0K shares

Days from execution to publication

4

What this establishes

Kauh John Saewook M.D. filed this Form 4 reporting a grant or award of TVRD on Jan 29, 2026. It became public on Feb 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Kauh John Saewook M.D.cik:0002064881

Issuer

Tvardi Therapeutics, Inc.cik:0001346830

Revision history · 0

No field has changed since this record was first ingested.